Business PARP-1 Inhibitors In Oncology

1. PARP-1 Inhibitors in Oncology The Discovery and Development of CEP-9722, an Orally Active Prodrug for the Treatment of Cancer 2. Rationale for PARP-1 Inhibitors in Oncology…